Innate Pharma SA (FR:IPH) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Innate Pharma SA has unveiled its 2025 financial calendar, with key dates for the release of its financial statements and shareholders meeting. Investors can expect updates on March 27, May 13, September 17, and November 13, as the company continues to advance its innovative cancer immunotherapies. Innate Pharma, listed on Euronext Paris and Nasdaq, partners with major biopharmaceutical firms like Sanofi and AstraZeneca.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.
